Avisana

Avisana is a German biotechnology company focused on developing innovative microbiome-based therapies for chronic inflammatory and infectious diseases. The company leverages its proprietary platform to identify and utilize specific beneficial microorganisms and their metabolites to restore healthy microbial balance in various human niches, including the skin and vaginal tract. Its lead programs target common conditions such as bacterial vaginosis and atopic dermatitis, aiming to provide more effective and sustainable alternatives to traditional antibiotic treatments. By focusing on the modulation of the human microbiome, Avisana seeks to address the root causes of inflammation rather than just managing symptoms.